Patents by Inventor Matthew J. Wyvratt, Jr.
Matthew J. Wyvratt, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6162813Abstract: There are disclosed compounds of formula (I) and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related conditions in both men and women.Type: GrantFiled: November 12, 1998Date of Patent: December 19, 2000Assignee: Merck & Co., Inc.Inventors: Mark Goulet, Robert J. Devita, Matthew J. Wyvratt, Jr., Jonathan R. Young
-
Patent number: 6156767Abstract: There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.Type: GrantFiled: May 22, 1998Date of Patent: December 5, 2000Assignee: Merck & Co., Inc.Inventors: Mark Goulet, Matthew J. Wyvratt, Jr., Peter Lin, Lin Chu, Narindar N. Girotra
-
Patent number: 6156772Abstract: There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.Type: GrantFiled: May 14, 1999Date of Patent: December 5, 2000Assignee: Merck & Co., Inc.Inventors: Mark Goulet, Thomas F. Walsh, Feroze Ujjainwalla, Matthew J. Wyvratt, Jr.
-
Patent number: 6150522Abstract: There are disclosed compounds of formula (I) and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related conditions in both men and women.Type: GrantFiled: November 12, 1998Date of Patent: November 21, 2000Assignee: Merck & Co., Inc.Inventors: Mark Goulet, Robert J. DeVita, Matthew J. Wyvratt, Jr., Jonathan R. Young
-
Patent number: 6150352Abstract: There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related conditions in both men and women.Type: GrantFiled: November 12, 1998Date of Patent: November 21, 2000Assignee: Merck & Co., Inc.Inventors: Mark Goulet, Eric E Allen, Matthew J. Wyvratt, Jr., Jinlong Jiang, Richard B. Toupence, Thomas F Walsh, Feroze Ujjainwalla, Jonathan R Young, Robert J. Devita
-
Patent number: 6147088Abstract: There are disclosed compounds of formula (I) and pharmaceutical acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related conditions.Type: GrantFiled: November 12, 1998Date of Patent: November 14, 2000Assignee: Merck & Co., Inc.Inventors: Mark Goulet, Eric E Allen, Matthew J. Wyvratt, Jr., Jinlong Jiang, Roy G. Smith, Thomas F Walsh, Yi Tien Yang, Jonathan R Young, Robert J. Devita
-
Patent number: 6077858Abstract: There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.Type: GrantFiled: September 21, 1999Date of Patent: June 20, 2000Assignee: Merck & Co., Inc.Inventors: Mark Goulet, Feroze Ujjainwalla, Thomas F. Walsh, Matthew J. Wyvratt, Jr., Jonathan R. Young, Lin Chu
-
Patent number: 6004984Abstract: There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.Type: GrantFiled: May 22, 1998Date of Patent: December 21, 1999Assignee: Merck & Co., Inc.Inventors: Mark Goulet, Feroze Ujjainwalla, Thomas F. Walsh, Matthew J. Wyvratt, Jr.
-
Patent number: 5985901Abstract: There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.Type: GrantFiled: May 22, 1998Date of Patent: November 16, 1999Assignee: Merck & Co., Inc.Inventors: Mark Goulet, Feroze Ujjainwalla, Thomas F. Walsh, Matthew J. Wyvratt, Jr., Jonathan R. Young, Lin Chu
-
Patent number: 5981550Abstract: There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.Type: GrantFiled: May 22, 1998Date of Patent: November 9, 1999Assignee: Merck & Co., Inc.Inventors: Mark Goulet, Thomas F. Walsh, Feroze Ujjainwalla, Matthew J. Wyvratt, Jr., Jonathan R. Young, Lin Chu
-
Patent number: 5545735Abstract: There are disclosed certain novel compounds identified as benzo-fused lactams which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to increase the stature of those afflicted with a lack of a normal secretion of natural growth hormone. Growth promoting compositions containing such benzo-fused lactams as the active ingredient thereof are also disclosed.Type: GrantFiled: October 4, 1993Date of Patent: August 13, 1996Assignee: Merck & Co., Inc.Inventors: Richard J. Bochis, Paul J. Hodges, William R. Schoen, Matthew J. Wyvratt, Jr.
-
Patent number: 5438136Abstract: There are disclosed certain novel compounds identified as benzo-fused macrocycles which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to increase the stature of those afflicted with a lack of a normal secretion of natural growth hormone. Growth promoting compositions containing such benzo-fused macrocycles as the active ingredient thereof are also disclosed.Type: GrantFiled: November 2, 1993Date of Patent: August 1, 1995Assignee: Merck & Co., Inc.Inventors: Robert J. Devita, William R. Schoen, Alison J. Frontier, Matthew J. Wyvratt, Jr.
-
Patent number: 5434261Abstract: There are disclosed certain novel compounds identified as benzo-fused lactams which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to increase the stature of those afflicted with a lack of a normal secretion of natural growth hormone. Growth promoting compositions containing such benzo-fused lactams as the active ingredient thereof are also disclosed.Type: GrantFiled: July 26, 1993Date of Patent: July 18, 1995Assignee: Merck & Co., Inc.Inventors: William R. Schoen, Matthew J. Wyvratt, Jr.
-
Patent number: 5430144Abstract: There are disclosed certain novel compounds identified as benzo-fused lactams which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to increase the stature of those afflicted with a lack of a normal secretion of natural growth hormone. Growth promoting compositions containing such benzo-fused lactams as the active ingredient thereof are also disclosed.Type: GrantFiled: July 26, 1993Date of Patent: July 4, 1995Assignee: Merck & Co., Inc.Inventors: William R. Schoen, Matthew J. Wyvratt, Jr., Paul J. Hodges
-
Patent number: 5143918Abstract: Novel C-3" and C-4" halogen-substituted macrolides of FK-506 type structural Formula I: ##STR1## are described. These macrolide immunosuppressants are useful in a mammalian host for the treatment of autoimmune diseases (such as juvenile-onset diabetes melitus, multiple sclerosis and rheumatoid arthritis), infectious diseases and/or the prevention of rejection of foreign organ transplants, e.g. bone marrow and heart transplants. In addition, these macrolide immunosuppressants are useful in the topical treatment of inflammatory and hyperproliferative skin diseases and cutaneous manifestations of immunologically-mediated illnesses such as: psoriasis, atopical dermatitiis, contact dermatitis and further eczematous dermatitises, seborrhoeic dermatitis, Lichen planus, Pemphigus, bullous Pemphigoid, Epidermolysis bullosa, urticaria, angioedemas, vasulitides erythemas, cutaneous eosinophilias, Lupus erythematosus or Alopecia areata.Type: GrantFiled: September 12, 1991Date of Patent: September 1, 1992Assignee: Merck & Co., Inc.Inventors: Richard J. Bochis, Matthew J. Wyvratt, Jr.
-
Patent number: 5068323Abstract: Ring-expanded macrolides related to FK-506 have immunosuppressive activity.Type: GrantFiled: April 10, 1990Date of Patent: November 26, 1991Assignee: Merck & Co., Inc.Inventors: Matthew J. Wyvratt, Jr., Thomas R. Beattie, Hyun Ok, Byron H. Arison, Michael H. Fisher
-
Patent number: 5057608Abstract: Ring-expanded, immunosuppressive macrolides, are produced by heating and rearranging FK-506 and related compounds.Type: GrantFiled: April 10, 1990Date of Patent: October 15, 1991Assignee: Merck & Co., Inc.Inventors: Matthew J. Wyvratt, Jr., Thomas R. Beattie, Hyun O. Ok, Byron H. Arison, Michael H. Fisher
-
Patent number: 5019578Abstract: The instant invention concerns certain .alpha.-heterocyclic ethanol amines wherein the amine group is substituted with various alkyl and unsaturated alkyl groups optionally further substituted with hydroxy, or alkoxy groups of the formula: ##STR1## These compounds are useful as growth promotion agents in animals.Type: GrantFiled: April 9, 1990Date of Patent: May 28, 1991Assignee: Merck & Co., Inc.Inventors: Michael H. Fisher, Matthew J. Wyvratt, Jr.
-
Patent number: 4833168Abstract: There are disclosed novel avermectin compounds wherein the glycosyl side chain is substituted with, or replaced by an alkyl ester group in a Reformatsky reaction. The compounds are prepared by reacting an .alpha.-halogenated ester to a 4'-, 4"- or 13-keto-avermectin derivative in the presence of a reducing agent. The avermectin compounds have utility as anti-parasitic agents and compositions for that use are also disclosed. The compounds are also highly potent insecticides against agricultural pests.Type: GrantFiled: October 3, 1986Date of Patent: May 23, 1989Assignee: Merck & Co., Inc.Inventor: Matthew J. Wyvratt, Jr.
-
Patent number: 4731444Abstract: There are disclosed bicyclic lactams and derivatives thereof which are useful as converting enzyme inhibitors and as antihypertensives.Type: GrantFiled: August 3, 1984Date of Patent: March 15, 1988Assignee: Merck & Co., Inc.Inventors: William H. Parsons, Matthew J. Wyvratt, Jr.